Hebei Medical University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1894-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.hebmu.edu.cn
Clinical Observation of ICI Combined With Recombinant Human Endostatin on Leptomeningeal Metastasis of Lung Cancer
Phase 2
Recruiting
- Conditions
- Leptomeningeal MetastasisEndostatinImmune Checkpoint Inhibitor
- Interventions
- First Posted Date
- 2022-05-23
- Last Posted Date
- 2022-05-23
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 20
- Registration Number
- NCT05385185
- Locations
- 🇨🇳
The Second Hospital of Hebei Medical University, Hebei, China
Effect of CNSI vs. ICG in Lymph Node Tracing During Gastrectomy
Phase 2
Active, not recruiting
- Conditions
- Gastric Cancer
- Interventions
- First Posted Date
- 2022-02-08
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 96
- Registration Number
- NCT05229874
- Locations
- 🇨🇳
Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Percutaneous Screw Fixation for Acute Scaphoid Fractures Through K-wire-assisted Reduction and Maintenance
Not Applicable
Completed
- Conditions
- WristWounds and InjuriesHand
- Interventions
- Procedure: Percutaneous screw fixation through K-wire-assisted reduction and maintenance
- First Posted Date
- 2020-07-23
- Last Posted Date
- 2020-08-14
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 20
- Registration Number
- NCT04482868
Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy for Gastroesophageal Junction
Phase 3
- Conditions
- Gastroesophageal Junction Adenocarcinoma
- Interventions
- First Posted Date
- 2019-06-14
- Last Posted Date
- 2020-02-19
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 180
- Registration Number
- NCT03986385
- Locations
- 🇨🇳
QunZhao, Shijia Zhuang, Hebei, China
Repair of Thumb Defect by Using the Toe Nail Flap
Completed
- Conditions
- Thumb Injury
- First Posted Date
- 2019-03-19
- Last Posted Date
- 2019-03-19
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 29
- Registration Number
- NCT03879941
A Study of Intraperitoneal and Intravenous Paclitaxel Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells
Phase 2
- Conditions
- Gastric Cancer With Positive Exfoliative Cancer Cells
- Interventions
- First Posted Date
- 2018-10-24
- Last Posted Date
- 2018-10-31
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 36
- Registration Number
- NCT03718624
A Study of HIPEC Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells
- First Posted Date
- 2018-02-09
- Last Posted Date
- 2018-02-09
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 38
- Registration Number
- NCT03428425
Concurrent Neoadjuvant Chemoradiotherapy Plus Trastuzumab in the Treatment of Siewert II ，III of Human Epidermal Growth Factor Receptor-2(HER-2) Positive Gastroesophageal Junction Adenocarcinoma： A Randomized, Controlled Clinical Study
Phase 2
- Conditions
- Gastroesophageal Junction Adenocarcinoma
- Interventions
- First Posted Date
- 2017-12-11
- Last Posted Date
- 2020-02-19
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 48
- Registration Number
- NCT03368131
- Locations
- 🇨🇳
Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
A Prospective Study of Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy for Siewert II ，III of Locally Advanced HER-2 Negative Adenocarcinoma at Gastroesophageal Junction
Phase 2
- Conditions
- Gastroesophageal Junction Adenocarcinoma
- Interventions
- First Posted Date
- 2017-11-22
- Last Posted Date
- 2020-02-19
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 48
- Registration Number
- NCT03349866
- Locations
- 🇨🇳
The Fourth Hospital of Hebei Medical University, ShiJiaZhuang, Hebei, China
Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Systemic Lupus Erythematosus
Early Phase 1
- Conditions
- Systemic Lupus Erythematosus
- Interventions
- Biological: mesenchymal stem cells
- First Posted Date
- 2017-07-18
- Last Posted Date
- 2017-07-18
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 10
- Registration Number
- NCT03219801
- Locations
- 🇨🇳
the First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China